INTRODUCTION
Previous work has shown that injection of lithocholic acid (LCA-Na) and its taurine and glycine conjugates can induce intrahepatic cholestasis in experimental animals (Javitt, 1966; King & Schoenfield, 1971; Priestly et al., 1971; Miyai et al., 1975; . Several mechanisms have been suggested to explain the pathogenesis of this cholestasis Miyai et al., 1977; Bovicini et al., 1978; Kakis & Yousef, 1978 ; however, recent studies indicate that LCA-Na modifies the structural characteristics ofthe bile canalicular membrane, thereby possibly reducing its permeability to water and ions. These membrane changes are characterized by the binding of LCA-Na to the bile canalicular membrane and a rapid and extensive increase in its cholesterol content (Kakis & Yousef, 1978 . Microtubule-disrupting agents, such as colchicine and vinblastine, interfere with the movement of secretory vesicles within hepatocytes, resulting in an accumulation of secretory materials, e.g. albumin (Le Marchand et al., 1974) , fibrinogen (Feldmann et al., 1975) and lipoproteins Orci et al., 1973 ; Reaven & Reaven, 1980) , inside the liver cells and diminishing their secretion into the blood (Le Marchand et al., 1974; Feldmann et al., 1975; Le Marchand et al., 1973; Orci et al., 1973; Reaven & Reaven, 1980; Redman et al., 1975; . These agents also inhibit transcellular IgA transport into the bile Mullock et al., 1980; Godfrey et al., 1982; Goldman et al., 1983) , reduce the secretion of biliary lipids (Gregory et al., 1978; Dubin et al., 1980; Erlinger et al., 1980; Barnwell et al., 1984) , and have been suggested to play a role in bile salt transport (Gregory et al., 1978; Dubin et al., 1980; Erlinger et al., 1980) . In view of the reported effects of microtubule-disrupting agents on the output of biliary components, colchicine was used in the present study to investigate the possible role of microtubules in the cellular transport of LCA-Na and cholesterol to the bile canalicular membrane during the development of LCA-Na-induced cholestasis.
MATERIALS AND METHODS

Materials
Lithocholic acid, sodium salt (LCA-Na), was obtained from Calbiochem-Behring, La Jolla, CA, U.S. 07:00) with free access to food and water prior to experimental use.
Animals were anaesthetized with pentobarbital (48 mg/kg body wt., intraperitoneally) and a PE90 catheter was inserted into the jugular vein. The bile duct was cannulated with PEIO tubing and bile was collected for 15 min to ascertain that bile flow was normal. Body temperature was monitored throughout the experiment and maintained at a constant 37°C by using a rectal probe and a thermostatically controlled i.r. lamp.
After 15 min a second bile sample was collected and either colchicine (0.2 /tmol/ 100 g body wt.) or 1 ml of saline solution (controls) was administered via thejugular vein catheter. This dose of colchicine was previously found to cause a 60% inhibition of biliary IgA secretion and a 2-fold increase in biliary albumin output after 90 min of treatment, and therefore was taken as evidence that colchicine had inhibited microtubular function Godfrey et al., 1982 Yousef & Murray (1978) . Briefly, homogenates were diluted to 10 times their original volume with 1 mM-NaHCO3 buffer (pH 7.5), filtered through four layers of gauze, and centrifuged at 600 g for 15 min. The resulting crude membrane fraction contained in the pellet was suspended in sucrose, final density 1.22 g/ml. Aliquots of this solution were carefully overlayered with sucrose of density 1.18 g/ml and then with sucrose of density 1.16 g/ml. The pure bile canalicular membrane (BCM) fraction appeared at the 1.18/1.16 g/ml interface after centrifugation at 66000 g for 60 min (Song et al., 1969) . The fraction at the 1.22/1.18 g/ml interface consisted of the remaining plasma membranes (PM) contaminated with microsomes, mitochondria and other material. Each layer was harvested by syringe and needle and washed with 4 vol. ofice-cold 1 mM-NaHCO3 buffer (pH 7.5) and centrifuged at 3000 g for 10 min. The membranes were then again resuspended and washed with 50 ml of 1 mM-NaHCO3 buffer (pH 7.5) and recentrifuged at 9000 g for 10 min. Finally, BCM and PM pellets were resuspended in 2 ml of 1 mM-NaHCO3 buffer (pH 7.5) containing 2 mM-CaCl2 and stored at -70°C until required. Analytical methods activity was measured by the method of Schwartz & Bodansky (1961) and leucine aminopeptidase (EC 3.4.1 1.1) by the method of Goldbarg & Rutenberg (1958) ; alkaline phosphodiesterase 1 (EC 3.1.4.1), lactate dehydrogenase (EC 1. 1.1.27), 5'-nucleotidase (EC 3.1.3.5) and alkaline phosphatase (EC 3.1.3.1) were measured as described previously (Godfrey et al., 1981) . Protein was determined by the method of Lowry et al. (1951) .
Bile and membrane fractions were analysed for phospholipid by a similar method to that reported in and cholesterol content was determined by g.l.c. (see . Total biliary bile acids were determined by using 3a-hydroxysteroid dehydrogenase (EC 1.1.1.50) as described by Coleman et al. (1979) . Bile flow was determined gravimetrically, assuming a density of 1 g/ml.
Radioactivity in blood, bile and liver homogenate samples taken from animals injected with [14C]LCA-Na was measured in a Beckman liquid-scintillation counter equipped with an external standard. The distribution of [14C]LCA-Na metabolites in bile was also determined after first separating the individual bile acids by t.l.c. using butan-1 -ol/acetic acid/water (10:1:1, by vol.) as a solvent system and by comparison with pure standards of lithocholic acid, taurolithocholic acid, glycolithocholic acid and the taurine and glycine conjugates of cholic and chenodeoxycholic acids to identify the biliary components.
Ultrastructural methods
Liver samples were fixed in a solution containing 2.5 o glutaraldehyde in 0.1 M-cacodylate buffer (pH 7.4) for at least 1 h at 4 'C. After washing with buffer, blocks of tissue were post-fixed with 2% osmic acid in cacodylate buffer for 2 h, dehydrated in graded ethanol and embedded in Araldite. Thin sections were cut from centrolobular zones and were stained with aryl acetate and Reynold's lead citrate. At least three blocks of tissue from each liver were sectioned and later examined.
Statistical analysis of the data was carried out using Student's t test. Values of P < 0.05 were assumed to be significant. Table 1 shows that, following the injection of LCA-Na, there was a significant decrease in bile flow. However, the reduction in bile flow was much less (32%) following Table 3 ), it was found that there was no significant difference in the proportion of unchanged lithocholic acid and taurine-conjugated lithocholic acid (the bile acids known to cause cholestasis). However, there was a significant reduction in the proportion of dihydroxy taurine-conjugated bile acids secreted by colchicine-treated animals. Colchicine administration caused a decline in both biliary phospholipid and cholesterol secretion when compared with saline-treated controls (see Tables 4 and  5 ). The reduction in biliary cholesterol secretion (48%) during the second sample period (105-165 min) was considerably more marked than the reduction in phospholipid output, which was not significantly different from controls.
RESULTS
Bile flow
A bolus injection of LCA-Na reduced both biliary phospholipid (55% ) and cholesterol secretion (48% ) (see Tables 4 and 5 ). However, the cholesterol output was not significantly different from the group treated with colchicine alone (no LCA-Na). Plasma membrane enzyme activity in bile Alkaline phosphodiesterase 1 activity in bile (Table 6 ) was not significantly affected by colchicine or LCA-Na Table 6 . Effects of colchicine and LCA-Na on the biliary output of alkaline phosphodiesterase 1
Values are means + S.D., for six animals. Enzyme units are nmol of substrate hydrolysed/h at 37 'C. Output of enzyme was calculated by dividing the total activity present in a given sample by the number of minutes for which the bile collection was made. The activity of the other plasma membrane enzymes alkaline phosphatase and 5'-nucleotidase were also measured. These enzymes showed an increase in activity (10-fold) in the colchicine + LCA-Na group similar to that shown by alkaline phosphodiesterase 1. The activity of this enzyme in bile was only found to be significantly different from controls in the treatment group which received both colchicine and LCA-Na (P < 0.001). This value is marked a. injection when compared with untreated controls. However, a combination of colchicine and LCA-Na caused a 10-fold increase in alkaline phosphodiesterase 1 activity. A similar effect was also observed with two other plasma membrane enzymes, alkaline phosphatase and 5'-nucleotidase (results not shown). These results could not be due to biliary enzyme activation by an interaction of these enzymes with LCA-Na and colchicine together since no difference in activities were observed when these agents were incorporated into any of the enzyme incubations at levels similar to those found in sample bile (LCA-Na, 0-25 mM; colchicine, 0-50 nM).
Composition of liver plasma membranes Table 7 shows that the isolated BCM contained high specific activities of the plasma membrane enzymes 5'-nucleotidase and leucine aminopeptidase. The microsomal enzyme, glucose-6-phosphatase, and the cytosolic enzyme, lactate dehydrogenase, were absent from the purified BCM, indicating little contamination was present. These characteristics of the purified membrane BCM fraction and the total homogenate activities of all the liver enzymes used in this study were not significantly affected by any ofthe treatments used (results not shown).
The results in Table 8 indicate that LCA-Na caused an almost 2-fold increase in BCM cholesterol content when compared with controls. Colchicine treatment alone resulted in a significantly decreased membrane cholesterol content (52%). Injection of LCA-Na into colchicinetreated animals caused a significant increase in total liver plasma membrane cholesterol content; however, this was not as extensive as with LCA-Na injection alone. No Table 7 . Enzyme activities of rat liver membranes Values are means + S.E.M. of activities measured in six samples using determinations in triplicate for each enzyme assay. Enzyme activity is expressed as ,umol of NADH oxidized/h per mg of protein (lactate dehydrogenase), ,tmol of inorganic phosphate released/h per mg of protein (glucose-6-phosphatase and 5'-nucleotidase) or,ug offl-naphthylamine released/h per mg ofprotein (leucine aminopeptidase) at 37 'C. Samples in which no enzyme activity was detected are labelled ND. No significant statistical variation was found between any of the treatment groups with respect to total enzyme activities in homogenate, BCM or PM. significant change in membrane phospholipid or protein content was detected among the various groups (Table 8) .
Electron microscopy LCA-Na injection caused morphological alterations in bile canalicular membrane structure similar to those already published (Javitt, 1966; King & Schoenfield, 1971; Priestly et al., 1971; Miyai et al., 1975; . These changes consisted of canalicular dilation, partial loss of microvilli and the appearance of lamellar structures within the canalicular lumen. Colchicine treatment caused an accumulation of many multivesicular bodies within hepatocytes as previously observed . Liver samples taken after treatment with both colchicine and LCA-Na showed hepatocytes packed with multivesicular bodies yet containing fewer LCA-Na-induced lesions.
DISCUSSION
Previous studies indicate that LCA-Na-induced cholestasis is associated with a retention of this bile salt within the liver (Kakis & Yousef, 1978 . Cytochemical staining techniques (Bovicini et al., 1978; Jung et al., 1982) together with cell fractionation studies Bovicini et al., 1-978; have shown that cholestasis is also accompanied by an increase in the cholesterol content of the bile canalicular membrane and an increased binding of LCA-Na. The precise mechanism(s) by which bile flow is impaired is as yet unclear; however, it is possible that disruption of the bile canalicular membrane structure with large quantities of cholesterol may render the membrane less permeable to water and ions (Kakis & Yousef, 1978 .
In the present study colchicine was found to reduce significantly the cholestatic effect of LCA-Na (Table 1) and it is of note that this effect is accompanied by a reduction in the total cholesterol content of the BCM when compared with LCA-Na alone. However, it is noticeable (see Table 8 ) that colchicine alone reduces BCM cholesterol content to a value well below that measured in controls. Interestingly, however, the amount of cholesterol accumulated in the BCM following LCA-Na injection appeared to be similar irrespective of colchicine or saline pretreatment [LCA-Na versus control, 245 + 22 (S.E.M.) nmol/mg ofmembrane protein; LCA-Na+colchicine versus colchicine alone, 210+35 (S.E.M.) nmol/mg; P value not significant]. Together these observations suggest that an important determinant in the pathogenesis of LCA-Na is the total amount of cholesterol accumulated in the bile canalicular membrane. Further support for this idea is derived from studies in which inhibitors of cholesterol biosynthesis reduced both the accumulation of cholesterol in the bile canalicular membrane and any extensive decline in bile flow (Kugelmass et al., 1982) .
Since LCA-Na administration results in a similar quantity of cholesterol being transported to the BCM, both in saline-and colchicine-treated animals, and given that colchicine treatment by itself reduces BCM and biliary cholesterol content, it is suggested that the reduced cholestasis with LCA-Na after pretreatment with colchicine is the result of inhibition of a normal physiological and microtubule-dependent transport of cholesterol into the BCM and bile. Thus, in view of these results it is likely that LCA-Na can mobilize cholesterol by a completely microtubule-independent transport mechanism. This alternative cholesterol (and/or LCA-Na) transport mechanism may involve binding to cytosolic protein, since studies in vitro have shown that LCA-Na induced incorporation of microsomal cholesterol into isolated bile canalicular membranes is enhanced in the presence of a protein-containing fraction derived from liver cytosol . Furthermore, other studies have shown that inhibition of protein synthesis with cycloheximide prevents LCA-Na-induced cholestasis and diminishes LCA-Na binding to cytosolic protein (Yousefet al., 1983 ). An alternative explanation for the reduced cholestatic effect of LCA-Na following colchicine treatment could be that this agent in some way allows the LCA-Na to be converted to a less toxic metabolite(s). However, the results in Table 3 show that colchicine caused no significant change in the proportion of LCA-Na excreted as lithocholic acid or taurolithocholic acid (bile acids known to cause the cholestatic effect). The only significant change caused by colchicine was a reduction in the amount of [14C]LCA-Na excreted as dihydroxy taurine-conjugated bile acids. It is likely that this change can in part be accounted for by an increase in the excretion of glycine-conjugated bile acids.
Yet another alternative explanation for the reduced cholestatic effect of LCA-Na following colchicine treatment is that this agent prevents the uptake and transcellular transport of LCA-Na by the liver, thereby preventing the full development of cholestasis. However, as the amount of LCA-Na remaining in the circulation was similar in both colchicine-treated and control animals, this suggestion is unlikely (see Table 2 ). Furthermore, since the uptake of LCA-Na remained unaffected, and the biliary secretion was slightly increased, it is also unlikely that microtubules play a significant role in the transcellular transport of this bile salt.
The increased activity ofplasma membrane enzymes in the bile following LCA-Na administration to colchicinetreated animals is difficult to explain, since this bile salt is not a detergent and does not normally promote the biliary secretion of these enzymes into bile (see Table 8 and Reichen et al., 1979) .
In a number of studies in which bile salts, other than LCA-Na, have been infused into bile fistula rats or isolated perfused rat livers treated with microtubuledisrupting agents the expected increase in biliary phospholipid secretion was virtually abolished (Gregory et al., 1978; Barnwell et al., 1984; Berken et al., 1982; Fukumoto et al., 1982) . The present study demonstrated that the reduction in biliary phospholipid secretion by colchicine-treated rats did not reach statistical significance (Table 4) , an observation which agrees with the findings of Stein et al. (1972) . However, in these investigations the measurement of biliary phospholipid secretion was made when the enterohepatic circulation had been interrupted and the endogenous bile salt pool substantially depleted. Furthermore, in addition to these observations, it has been noted that disruption of the hepatocellular microtubule network results in abnormal biliary secretion of newly synthesized plasma proteins normally destined for delivery to the sinusoidal face of the hepatocyte . In view of these findings it Vol. 236 is possible to envisage that disruption of the resupply of biliary phospholipids and an increase in the delivery of abnormal membrane phospholipids, in the form of misdirected secretory vesicles, to the bile canalicular membrane following colchicine treatment could result in qualitative changes to its composition. These changes in structure, combined with the increase in membrane cholesterol content caused by LCA-Na, may therefore render the plasma membrane enzymes more easily detached by the membrane-perturbing (non-detergent) effect ofthis agent (Cooper et al., 1972) . That it is LCA-Na itself which causes the release of the plasma membrane enzymes is made more plausible by the observation that colchicine does not enhance the conversion of LCA-Na into more hydrophilic (detergent) bile acids (Table 3) .
In summary, therefore, it can be said that microtubules probably do not play a role in the transcellular transport ofLCA-Na, or in LCA-Na-induced cholesterol transport. However, since colchicine interferes with the physiological transport ofcholesterol to the bile canalicular membrane, thereby reducing the absolute amount present in the membrane, it -is suggested that the total cholesterol content ofthe bile canalicular membrane is the important determinant in LCA-Na-induced cholestasis.
